Halozyme Therapeutics Inc. Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.46B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 2.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Viking Holdings Ltd Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| HALO | VIK | |
|---|---|---|
Market Cap | $12.58B | $36.46B |
Volume | 2,179,278 | 3,461,906 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $108.26 |
52-Week Low | $61.63 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $38.84B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →